Thomas Hallam

Insider Reports History

Entity
Individual
Location
C/O Seneca Biopharma, Inc., 20271 Goldenrod Lane, Germantown, MD
Signature
/s/ JD Finley, Attorney-in-Fact for Thomas Hallam
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Hallam:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PALISADE BIO, INC. Chief Executive Officer, Director Common Stock, par value $0.01 57.6K $29.4K $0.51 Aug 16, 2022 Direct
PALISADE BIO, INC. Chief Executive Officer, Director Series 1 Common Stock Purchase Warrant 40K Aug 16, 2022 Direct
PALISADE BIO, INC. Chief Executive Officer, Director Series 2 Common Stock Purchase Warrant 40K Aug 16, 2022 Direct

Insider Reports Filed by Thomas Hallam

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PALI PALISADE BIO, INC. Aug 16, 2022 3 $10K 4 Aug 18, 2022 Chief Executive Officer, Director
PALI PALISADE BIO, INC. Mar 28, 2022 1 $11.8K 4 Mar 29, 2022 Chief Executive Officer, Director
PALI PALISADE BIO, INC. Feb 17, 2022 1 $0 4 Feb 22, 2022 Chief Executive Officer, Director
PALI PALISADE BIO, INC. Nov 18, 2021 1 $0 4 Feb 10, 2022 Chief Executive Officer, Director
PALI PALISADE BIO, INC. Sep 21, 2021 1 $14.9K 4 Sep 22, 2021 Chief Executive Officer, Director